Richard Sutton, MD/PhD
Internal Medicine, Infectious Diseases, HIV & AIDs Medicine
Titles
- Professor of Medicine (Infectious Diseases) and of Microbial Pathogenesis; Chief, Infectious Diseases at VACT
Education & Training
- Post-doctoral fellowUCSF then Stanford University (1998)
- FellowUC San Francisco (1993)
- ResidentHospital University of Pennsylvania (1992)
- MD/PhDStanford University School of Medicine (1989)
Additional Information
Honors & Recognitions
- 2013 Avant Garde Scholar: NIH-NIDA (2013)
- Edward Mallinckrodt Jr. Foundation Scholar: Edward Mallinckrodt, Jr. Foundation (St. Louis, MO) (2001)
- Pfizer Postdoctoral Scholar Award: Pfizer Pharmaceutical Company (1993)
Professional Service
- NIH-NIAID & NIH-NIDA (2003 - Present): Study Section
Publications
- Slotkin R, Kyriakides T, Kundu A, Stack G, Sutton R, Gupta S. Correlation of a commercial platform’s results with post-vaccination SARS-CoV-2 neutralizing antibody response and clinical host factors. PLOS ONE 2023, 18: e0289713. PMID: 37643190, PMCID: PMC10464955, DOI: 10.1371/journal.pone.0289713.
- Kiros Y, Elinav H, Gebreyesus A, Gebremeskel H, Azar J, Chemtob D, Abreha H, Elbirt D, Shahar E, Chowers M, Turner D, Grossman Z, Haile A, Sutton R, Maayan S, Wolday D. Identification and characterization of HIV positive Ethiopian elite controllers in both Africa and Israel. HIV Medicine 2018, 20: 33-37. PMID: 30318718, PMCID: PMC6510948, DOI: 10.1111/hiv.12680.
- Elinav H, Sutton R. Cell-Intrinsic Immunity. 2018, 231-240. DOI: 10.1007/978-1-4939-7101-5_270.
- Elinav H, Sutton R. Cell-Intrinsic Immunity. 2014, 1-11. DOI: 10.1007/978-1-4614-9610-6_270-1.
- Sutton R. What does the future hold for viral gene therapy? Future Virology 2007, 2: 543-547. DOI: 10.2217/17460794.2.6.543.
- Rice A, Sutton R. Targeting proteinprotein interactions for HIV therapeutics. HIV Therapy 2007, 1: 369-385. DOI: 10.2217/17469600.1.4.369.
- Coskun A, van Maanen M, Janka D, Stockton D, Stankiewicz P, Yatsenko S, Sutton R. Corrigendum to “Isolation and characterization of mouse–human microcell hybrid cell clones permissive for infectious HIV particle release” [Virology 362 (2007) 283–293]. Virology 2007, 365: 473. DOI: 10.1016/j.virol.2007.06.003.
- Conklin L, LeMaire S, Coselli J, McAninch R, Sutton R. HIV-based vectors for therapeutic angiogenesis in a rabbit model of hindlimb ischemia. Journal Of Surgical Research 2003, 114: 284. DOI: 10.1016/j.jss.2003.08.045.
- Kumar M, Keller B, Makalou N, Sutton R. Systematic Determination of the Packaging Limit of Lentiviral Vectors. Human Gene Therapy 2001, 12: 1893-1905. PMID: 11589831, DOI: 10.1089/104303401753153947.
- Schroers R, Sinha I, Segall H, Schmidt-Wolf I, Rooney C, Brenner M, Sutton R, Chen S. Transduction of Human PBMC-Derived Dendritic Cells and Macrophages by an HIV-1-Based Lentiviral Vector System. Molecular Therapy 2000, 1: 171-179. PMID: 10933928, DOI: 10.1006/mthe.2000.0027.
- Sutton R, Reitsma M, Uchida N, Brown P. Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. Journal Of Virology 1999, 73: 3649-60. PMID: 10196257, PMCID: PMC104140, DOI: 10.1128/jvi.73.5.3649-3660.1999.
- Uchida N, Sutton R, Friera A, He D, Reitsma M, Chang W, Veres G, Scollay R, Weissman I. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proceedings Of The National Academy Of Sciences Of The United States Of America 1998, 95: 11939-11944. PMID: 9751769, PMCID: PMC21744, DOI: 10.1073/pnas.95.20.11939.
- Sutton R, Wu H, Rigg R, Böhnlein E, Brown P. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. Journal Of Virology 1998, 72: 5781-8. PMID: 9621037, PMCID: PMC110379, DOI: 10.1128/jvi.72.7.5781-5788.1998.
- Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Marzio P, Marmon S, Sutton R, Hill C, Davis C, Peiper S, Schall T, Littman D, Landau N. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381: 661-666. PMID: 8649511, DOI: 10.1038/381661a0.
Departments and Programs
Titles
- Professor of Medicine (Infectious Diseases) and of Microbial Pathogenesis; Chief, Infectious Diseases at VACT
Education & Training
- Post-doctoral fellowUCSF then Stanford University (1998)
- FellowUC San Francisco (1993)
- ResidentHospital University of Pennsylvania (1992)
- MD/PhDStanford University School of Medicine (1989)
Additional Information
Honors & Recognitions
- 2013 Avant Garde Scholar: NIH-NIDA (2013)
- Edward Mallinckrodt Jr. Foundation Scholar: Edward Mallinckrodt, Jr. Foundation (St. Louis, MO) (2001)
- Pfizer Postdoctoral Scholar Award: Pfizer Pharmaceutical Company (1993)
Professional Service
- NIH-NIAID & NIH-NIDA (2003 - Present): Study Section
Publications
- Slotkin R, Kyriakides T, Kundu A, Stack G, Sutton R, Gupta S. Correlation of a commercial platform’s results with post-vaccination SARS-CoV-2 neutralizing antibody response and clinical host factors. PLOS ONE 2023, 18: e0289713. PMID: 37643190, PMCID: PMC10464955, DOI: 10.1371/journal.pone.0289713.
- Kiros Y, Elinav H, Gebreyesus A, Gebremeskel H, Azar J, Chemtob D, Abreha H, Elbirt D, Shahar E, Chowers M, Turner D, Grossman Z, Haile A, Sutton R, Maayan S, Wolday D. Identification and characterization of HIV positive Ethiopian elite controllers in both Africa and Israel. HIV Medicine 2018, 20: 33-37. PMID: 30318718, PMCID: PMC6510948, DOI: 10.1111/hiv.12680.
- Elinav H, Sutton R. Cell-Intrinsic Immunity. 2018, 231-240. DOI: 10.1007/978-1-4939-7101-5_270.
- Elinav H, Sutton R. Cell-Intrinsic Immunity. 2014, 1-11. DOI: 10.1007/978-1-4614-9610-6_270-1.
- Sutton R. What does the future hold for viral gene therapy? Future Virology 2007, 2: 543-547. DOI: 10.2217/17460794.2.6.543.
- Rice A, Sutton R. Targeting proteinprotein interactions for HIV therapeutics. HIV Therapy 2007, 1: 369-385. DOI: 10.2217/17469600.1.4.369.
- Coskun A, van Maanen M, Janka D, Stockton D, Stankiewicz P, Yatsenko S, Sutton R. Corrigendum to “Isolation and characterization of mouse–human microcell hybrid cell clones permissive for infectious HIV particle release” [Virology 362 (2007) 283–293]. Virology 2007, 365: 473. DOI: 10.1016/j.virol.2007.06.003.
- Conklin L, LeMaire S, Coselli J, McAninch R, Sutton R. HIV-based vectors for therapeutic angiogenesis in a rabbit model of hindlimb ischemia. Journal Of Surgical Research 2003, 114: 284. DOI: 10.1016/j.jss.2003.08.045.
- Kumar M, Keller B, Makalou N, Sutton R. Systematic Determination of the Packaging Limit of Lentiviral Vectors. Human Gene Therapy 2001, 12: 1893-1905. PMID: 11589831, DOI: 10.1089/104303401753153947.
- Schroers R, Sinha I, Segall H, Schmidt-Wolf I, Rooney C, Brenner M, Sutton R, Chen S. Transduction of Human PBMC-Derived Dendritic Cells and Macrophages by an HIV-1-Based Lentiviral Vector System. Molecular Therapy 2000, 1: 171-179. PMID: 10933928, DOI: 10.1006/mthe.2000.0027.
- Sutton R, Reitsma M, Uchida N, Brown P. Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. Journal Of Virology 1999, 73: 3649-60. PMID: 10196257, PMCID: PMC104140, DOI: 10.1128/jvi.73.5.3649-3660.1999.
- Uchida N, Sutton R, Friera A, He D, Reitsma M, Chang W, Veres G, Scollay R, Weissman I. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proceedings Of The National Academy Of Sciences Of The United States Of America 1998, 95: 11939-11944. PMID: 9751769, PMCID: PMC21744, DOI: 10.1073/pnas.95.20.11939.
- Sutton R, Wu H, Rigg R, Böhnlein E, Brown P. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. Journal Of Virology 1998, 72: 5781-8. PMID: 9621037, PMCID: PMC110379, DOI: 10.1128/jvi.72.7.5781-5788.1998.
- Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Marzio P, Marmon S, Sutton R, Hill C, Davis C, Peiper S, Schall T, Littman D, Landau N. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381: 661-666. PMID: 8649511, DOI: 10.1038/381661a0.
Departments and Programs